These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 32437303)

  • 1. Treatment of Obesity in Mitigating Metabolic Risk.
    Heffron SP; Parham JS; Pendse J; Alemán JO
    Circ Res; 2020 May; 126(11):1646-1665. PubMed ID: 32437303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of whole-body electromyostimulation exercise and caloric restriction on cardiometabolic risk profile and muscle strength in obese women with the metabolic syndrome: a pilot study.
    Reljic D; Konturek PC; Herrmann HJ; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32554843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity: a review of pathogenesis and management strategies.
    Kaila B; Raman M
    Can J Gastroenterol; 2008 Jan; 22(1):61-8. PubMed ID: 18209783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet, drugs, and surgery for weight loss.
    Med Lett Drugs Ther; 2015 Feb; 57(1462):21-8. PubMed ID: 25668315
    [No Abstract]   [Full Text] [Related]  

  • 6. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal obesity and adverse reproductive outcomes: reducing the risk.
    Marsh CA; Hecker E
    Obstet Gynecol Surv; 2014 Oct; 69(10):622-8. PubMed ID: 25336072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamentals of cardiometabolic risk factor reduction: achieving and maintaining weight loss with pharmacotherapy or bariatric surgery.
    Fabbrini E; Klein S
    Clin Cornerstone; 2008; 9(1):41-8; discussion 49-51. PubMed ID: 19046739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral interventions for obesity.
    Berkel LA; Poston WS; Reeves RS; Foreyt JP
    J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S35-43. PubMed ID: 15867894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current treatment of obesity].
    Pados G
    Orv Hetil; 2010 Mar; 151(12):501-4. PubMed ID: 20231134
    [No Abstract]   [Full Text] [Related]  

  • 13. Bariatric Surgery versus Intensive Medical Weight Management for Type 2 Diabetes.
    Sethi M; Parikh M
    Adv Surg; 2015; 49():157-71. PubMed ID: 26299497
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of obesity in 2015.
    Shukla AP; Buniak WI; Aronne LJ
    J Cardiopulm Rehabil Prev; 2015; 35(2):81-92. PubMed ID: 25714749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.
    Bays H; Dujovne CA
    Curr Atheroscler Rep; 2006 Mar; 8(2):144-56. PubMed ID: 16510049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial.
    Yassine HN; Marchetti CM; Krishnan RK; Vrobel TR; Gonzalez F; Kirwan JP
    J Gerontol A Biol Sci Med Sci; 2009 Jan; 64(1):90-5. PubMed ID: 19164269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of weight loss on nonalcoholic fatty liver disease.
    Patel AA; Torres DM; Harrison SA
    J Clin Gastroenterol; 2009; 43(10):970-4. PubMed ID: 19727004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocannabinoid system as a target for obesity treatment.
    Aronne LJ; Pagotto U; Foster GD; Davis SN
    Clin Cornerstone; 2008; 9(1):52-64; discussion 65-6. PubMed ID: 19046740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of obesity.
    Bray GA; Frühbeck G; Ryan DH; Wilding JP
    Lancet; 2016 May; 387(10031):1947-56. PubMed ID: 26868660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?
    Ashrafian H; Harling L; Darzi A; Athanasiou T
    Metab Brain Dis; 2013 Sep; 28(3):341-53. PubMed ID: 23653255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.